Ajanta Pharma Promoter Releases 17.3 Lakh Shares from Pledge

Ravi Agrawal, a promoter of Ajanta Pharma Limited, has disclosed the release of a pledge on 17,32,792 equity shares. The disclosure, made on June 26, 2026, under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, cites 'Excess Pledge' as the reason for the release. The shares were released from pledges made to various lenders including Tata Capital Limited, Deutsche Investments India Private Limited, Infina Finance Private Limited, and Adity Birla Capital Limited. This action reduces the promoter's encumbered shareholding.